1981
DOI: 10.1016/s0016-5107(81)73151-1
|View full text |Cite
|
Sign up to set email alerts
|

Dissolution of retained duct stones by perfusion with monooctanoin via a Teflon catheter introduced endoscopically

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1983
1983
1989
1989

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(3 citation statements)
references
References 7 publications
0
3
0
Order By: Relevance
“…In addition, the tube can be irrigated with solutions to help expel stones. Solvents such as monooctanoin can be perfused via the N-B tube to shrink large stones and facilitate passage [56][57][58]. Nasobiliary drainage is especially valuable for temporary drainage of obstruction due to benign or malignant bile duct lesions.…”
Section: Nasobiliary Drainagementioning
confidence: 99%
“…In addition, the tube can be irrigated with solutions to help expel stones. Solvents such as monooctanoin can be perfused via the N-B tube to shrink large stones and facilitate passage [56][57][58]. Nasobiliary drainage is especially valuable for temporary drainage of obstruction due to benign or malignant bile duct lesions.…”
Section: Nasobiliary Drainagementioning
confidence: 99%
“…There is a choice between reoperation, endoscopic sphincterotomy, [4][5][6][7][8][9][10] Dormia basket extraction through the T-tube tract, 11,12 and infusion of monooctanoin through the T-tube to fragment and dissolve retained stones. [13][14][15][16][17][18] Thistle and colleagues 18 screened solvents to find a safe agent with high capacity for cholesterol monohydrate solubilization. Before that, sodium cholate was used as a cholesterol solvent but required perfusion for several weeks to bring about complete stone dissolution.…”
mentioning
confidence: 99%
“…15,18,[23][24][25] The aim of this study was to find a convenient method of mono-octanoin infusion, to confirm its efficacy in dissolution of radiolucent retained common bile duct stones, to find a means to reduce the incidence of side effects, and to define eligibility for this treatment.…”
mentioning
confidence: 99%